| NDC Code | 33332-125-10 |
|---|
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (33332-125-10) / 5 mL in 1 VIAL, MULTI-DOSE (33332-125-11) |
|---|
| Product NDC | 33332-125 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Afluria |
|---|
| Non-Proprietary Name | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (propiolactone Inactivated) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20250701 |
|---|
| End Marketing Date | 20260731 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125254 |
|---|
| Manufacturer | Seqirus PTY LTD. |
|---|
| Substance Name | INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) |
|---|
| Strength | 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL |
|---|